MissCate

@conquertheno Rum

Which alcohol was it for you?

@Kristinartz You didn’t gag. I responded with “I never do”.

What's the most unprofessional thing a doctor has ever said to you?

Do you remember when you joined X? I do! #MyXAnniversary

The hydraulic pin holding the tower arm in place did not retract. If that can be fixed tonight, there will be another launch attempt tomorrow at 5:30 CT.

Most people are using Retatrutide wrong. Here is the masterclass. 00:00 Intro and why I'm doing these masterclasses 04:04 The two users: weight loss vs longevity 05:30 What Retatrutide actually does 07:54 Weight loss trial data (1mg to 12mg) 10:50 The longevity data most people ignore 13:50 The titration playbook 21:02 Why 8mg is the real ceiling for most people 22:50 How long to stay on and the regain problem 27:24 Protein and training are non-negotiable 30:20 The heart rate question and why I use taurine 32:00 The weird skin sensitivity issue on Reta 33:48 Pairing Retatrutide with testosterone 39:54 The most common mistakes 46:50 The Ten Commandments of Retatrutide use

@Rightanglenews Peptides!

72-year-old John Travolta is the newest Hollywood celebrity to get a brand new face, debuting it at the 2026 Cannes Film Festival where shocked viewers say the actor looks 20 or even 30 years younger.

@C_3C_3 His girlfriend is a billionaire. He doesn’t care.

Travis Kelce looks absurd.

@ProjectGokuu Doesn’t sugar feed cancer?

Louisa Nicola says peptides are too risky to take. Not one peptide on the gray market has been through a human safety trial. Zero. BPC-157 is not FDA approved. The FDA blocked compounding pharmacies from using it because of insufficient safety data Yet people are buying it on the black market and injecting it anyway. She also says it also new blood vessels in your body and so do cancer cells. It could potentially help cancer cells grow. In her words: "The same people that are scared of vaccines are the ones buying peptides on the gray market. Make it make sense." You don't know what's in the bottle. You don't know what it's doing to your body. — Louisa Nicola (@louisanicola_) on the Shawn Ryan’s (@ShawnRyanShow) podcast

@brooksrunning my husband refuses to buy another pair of Brooks! He insists on wearing these!🤦‍♀️

@JCHerts @DrJesseMorse Many people use both.

@DrJesseMorse People will still use tirz over retatrutide due to stronger appetite suppression and reduced increased heart rate. I don’t think it’s a one size fits all here

Some thoughts on GLPs. Fast forward 5 years from now. We will see that for all the ‘weight loss’ drugs and peptides, the field will keep advancing. The first real successful one was Ozempic/Semaglutide starting 2017, and really becoming popular over the last 2-3 years. As the side effects mounted, people sought other answers. Enter Mounjaro/Tirzepatide, which was approved in 2022, and it was more effective for weight loss, less muscle wasting, and less side effects (nausea, gastric emptying). Then over the past year or so people have been exposed to the next big GLP1: Retatrutide predominantly via the black/gray market. Reta targets 3 receptors, compared to ozempic’s 1 and mounjaro’s 2. My guess is this will be formally available in late 2026 or early 2027 once the drug trials are completed, and it will dominate for the next 2 to 5 years. Potentially a trillion dollar drug. Why? Because it is significantly more effective than both Ozempic and Mounjaro for weight loss, very little side effects (no nausea or muscle wasting), has benefits for liver fat, inflammation, osteoarthritis pain and overall metabolic syndrome. I wouldn’t be surprised if it is seen as anti-cancer and anti-aging as well. Going forward, we will see that as the pharmaceutical companies continue to add drugs that target more receptors, the potency and treatment options/possibilities will increase, but the side effects will decrease. We will see that their side effect profiles of Ozempic/Semaglutide or Mounjaro/tirzepatide are very poor (comparatively) and there are better, safer and more cost-effective options. As a result, people will no longer recommend Ozempic/Semaglutide or Mounjaro/tirzepatide. The new ones will not only target weight loss, but also optimize blood sugars, abdominal fat, cravings, overall inflammation as well as work on building muscle. Gone will be the slow gastric emptying, which has caused significant issues with anesthesia, as well as the significant muscle wasting, in particularly in the face (‘Ozempic face’) and glutes. The future is bright and filled with less side effects!

@GoingParabolic Completely off BP meds!

Retatrutide trial results are straight-up insane: •86% liver fat reduction •72% prediabetes reversal •41% completely off BP meds •14 mmHg blood pressure drop •Raises resting metabolic rate It crushes appetite and makes you burn more calories at rest. One compound. All of that. Mind officially blown. This is next-level. 🔥

@EricLDaugh Is she having a boy?

🚨 WOW! This is Karoline Leavitt's last press appearance before having her baby ❤️ "This will likely be my last gaggle for some time. As you can see, I'm about ready to have a baby any minute. So I will see you guys very soon!" "I know you'll be in very good hands with my team here at the White House. And I know all of you have the president's phone number personally. So I have no doubt that you will have a shortage of statements and news from this building while I'm gone." @RapidResponse47 @karolineleavitt

@MLFootball He’s already living on year two money.

🚨TRENDING: This video of #Chiefs first-round pick Peter Woods and his family after he was drafted has gone viral on social media. Multiple family members were wearing wedding gowns and very expensive clothing. Woods contract is worth over $17 million.

@SaltyGoat17 He looks ill.

Who else would REALLY like to see this motherfcker in prison?

@JJ21338337 @SciGuySpace My guess is that will be postponed.

@SciGuySpace Well the word is that on April 17, the CEO is supposed to give a big update, right? My prediction is that employees on the legacy equity incentive plan will be allow to convert their stock units to credits on the Blue Origin merch store at a 100:1 ratio.

Story coming in a bit on Blue Origin's new stock option plan. One person described it as "pure fucking trash," so things seem to be going well with employee morale as Blue approaches a critical New Glenn launch.

@SciGuySpace Many people already looking for other jobs - So I hear.

@torybruno Big Ben

Let’s play a game. My favorite number is 7. Who am I?

Booster 3 almost done… "No, It's Necessary" Welcome to the fleet.

@UgaritNoosphere @SciGuySpace @elonmusk @SpaceX We never thought Elon would land a booster either. Always made fun of him - Look at him now.

@misscate12 @SciGuySpace @elonmusk @SpaceX Never gonna happen

You're probably going to be disappointed with the video imagery of the lunar flyby. Here's why: arstechnica.com/space/2026/04/…

@AlrightyD @SciGuySpace @elonmusk @SpaceX 😆 I work old ass SLS. I like the new tech better.

@misscate12 @SciGuySpace @elonmusk @SpaceX of course you can’t